Tech Company Financing Transactions
Variant Bio Funding Round
Variant Bio, based in Brooklyn, scored $16 million from Lux Capital and private investors.
Transaction Overview
Company Name
Announced On
6/1/2020
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Undisclosed
Investors
Lux Capital (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
19 Morris Ave. Building 128
Brooklyn, NY 11205
USA
Brooklyn, NY 11205
USA
Phone
Undisclosed
Website
Email Address
Overview
Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Farnum
Chief Scientific Officer
Kaja Wasik
Chief Technical Officer
Stephane Castel
Browse more venture capital transactions:
Prev: 5/29/2020: Almanac venture capital transaction
Next: 6/1/2020: Cabana Travel venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs